Northpond Ventures
Venture capitalBethesda · Seed–Series A · 41 people tracked
Also known as NORTHPOND VENTURES, LLC
Investment thesis
Northpond Ventures focuses on identifying and supporting breakthrough science and technology-driven businesses. The firm partners closely with innovators and visionaries, emphasizing a science-driven approach to discovering the next major breakthroughs. Its stated goal is to build and support companies that create a marked, positive impact on humanity.
Source: firm website, verified Aug 3, 2026.
Team · 41 people
from the firm's website & public directories
What they invest in
from 11 of 14 portfolio companiesAI & Machine Learning ×8Biotech ×8Medical Devices ×6Healthtech ×5Deep Tech ×2Digital Health ×2SaaS ×2Cloud Computing ×1
HQs:United States×14
Investments · 14 tracked
founders shown can be your intro path908 Devices manufactures handheld mass spectrometry and chemical analysis devices for rapid detection in defense, security, and hazardous materials response applications.
Deep TechDefense TechHardwareMedical DevicesBoston, US
Kevin J. Knopp, PhD(CEO & Co-founder)J. Michael Ramsey(Director)Christopher Brown(Executive Officer)Joseph Griffith IV(Executive Officer)Corey Steffek(Director)Mark Spoto(Director)
Board seatSharon Kedar· per SEC Form D · $17.5M raise · filed Apr 2019
Inflammatix develops host-response-based molecular diagnostics tests to identify acute infections and sepsis in emergency and critical care settings.
AI & Machine LearningBiotechHealthtechMedical DevicesBurlingame, US
Tim Sweeney(Co-Founder and CEO)Purvesh Khatri(Co-Founder and Chief Scientist)JONATHAN ROMANOWSKY(Executive Officer)KENNETH BAHK(Director)DAVID PERSING(Director)STEVEN TABLAK(Director)
Octave develops blood-based biomarker tests for neurodegenerative diseases including multiple sclerosis, Parkinson's disease, and Alzheimer's disease.
AI & Machine LearningBiotechDigital HealthMedical DevicesMenlo Park, US
William Hagstrom(Founder and Chairman)Doug Biehn(President and CEO)
Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)Jiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)Robert Carson(Executive Officer, Director)Terry Lo(Director)Seth Benson(Executive Officer)Simona Levi(Executive Officer)
Boston, US
Board seatSharon Kedar· per SEC Form D · $20M raise · filed Mar 2020
BiotechWatertown, US
Daniel Ahlstedt(Executive Officer, Director)
BoardAndrew Lee(Director)Steven Kasok(Director)
Board seatPaxton Major· per SEC Form D · $23.1M raise · filed Dec 2024
New Haven, US
Daniel Wagner(Director)John Conley(Director)Gregory Ho(Director)Rong Fan(Director)Sean McKay(Executive Officer, Director)
Board seatSharon Kedar· per SEC Form D · $85M raise · filed Jan 2021
Cambridge, US
Steve Liapis(Director)Clinton Hansen(Executive Officer, Promoter)Elias Quijano(Director)Wesley Wong(Executive Officer, Director, Promoter)
Board seatSteve LiapisElias Quijano· per SEC Form D · $15M raise · filed Sep 2025
Vizgen provides spatial multiomics platforms that enable researchers, clinicians, and biopharma teams to map and analyze RNA and protein molecules at single-cell resolution for disease understanding and precision medicine applications.
AI & Machine LearningBiotechMedical DevicesCambridge, US
Peng Yin(Director)Fenel Eloi(Director)Robert Carson(Executive Officer, Director)Peng Ying(Executive Officer, Director)David R. Walt(Executive Officer, Director)
BoardAndrea Jackson(Director)
Board seatSharon Kedar· per SEC Form D
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US
Aditya Rajagopal(Director)Paul Flook(Executive Officer, Director)James C. Blair(Director)Gregory J. Gosch(Executive Officer, Director)Axel Scherer(Director)Alexander G. Dickinson(Director)
Culture Biosciences provides software and bioreactor hardware solutions for bioprocess development, enabling researchers to design, monitor, and analyze experiments remotely with cloud-native analytics and AI/ML insights.
AI & Machine LearningBiotechCloud ComputingHealthtechSan Francisco, US
Outcomes4Me is an AI-driven patient platform that integrates with NCCN clinical oncology guidelines to provide personalized cancer care guidance, treatment options, clinical trial recommendations, and genetic testing information.
AI & Machine LearningDigital HealthHealthtechCambridge, US
Maya R. Said(Founder and CEO)David Auckland(Director)David Fleshman(Director)
BoardAndrea Jackson(Director)
Scitara provides cloud-based integration and data management software for scientific laboratories, enabling connection of lab instruments and applications into a unified environment with AI-powered analytics.
AI & Machine LearningBiotechData & InfrastructureSaaSMarlborough, US
Ajit Nagral(CEO & Chairman)Rohit Khanna(Director)Geoff Gerhardt(Executive Officer, Promoter)Charles M. Hazard, Jr.(Director)Andrea Jackson(Director)Michael R. Stapleton(Director)
Uptime Health provides operational tools and preventive maintenance plans to healthcare practices to reduce downtime and ensure regulatory compliance.
Enterprise SoftwareHealthtechSaaSBoston, US
John Huysmans(Director)William Olsen(Executive Officer, Director)Jinesh Patel(Executive Officer, Director)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Northpond Ventures invest at?
- Northpond Ventures invests at the Seed, Series A stages.
- What is Northpond Ventures's typical check size?
- Northpond Ventures typically writes checks of $100K – $5M.
- What sectors does Northpond Ventures focus on?
- Northpond Ventures focuses on AI & Machine Learning, Biotech, Cleantech, Climate Tech, Deep Tech, Energy, Hardware, Healthtech, Medical Devices, Sector Agnostic.
- Where is Northpond Ventures located?
- Northpond Ventures is headquartered in Bethesda, US.
- Does Northpond Ventures lead rounds?
- Northpond Ventures typically participates in rounds rather than leading them.
Images
Co-investors · 45
ARCH Venture Partners is a venture capital firm that backs and helps build transformational companies, with a strong focus on the life sciences and biotech sector.
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
Flybridge Capital Partners is an early-stage venture firm backing founders building AI-driven companies, from AI infrastructure and agentic business applications to entirely AI-native products.
S32 is a high-conviction venture firm that concentrates on a small set of core relationships, committing deeply and supporting founders over the long term.
Sandbox Industries is an investment firm that fosters innovation in the healthcare and insurance industries, partnering with corporate strategic investors as limited partners alongside financial investors and portfolio companies.
E14 Fund is an early-stage venture capital firm connected to MIT that backs founders building future-shaping technology companies.
Vensana Capital is a venture capital and growth equity investment firm focused on partnering with entrepreneurs building breakthrough medical technology innovations to transform healthcare.
Echo Health Ventures is a strategic venture capital and growth equity investor that partners with health care companies to help build and scale their innovations nationally.
GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.
New Enterprise Associates (NEA) is a venture capital firm that invests in and provides long-term support to founders building new companies.
First Round Capital is an early-stage venture firm that partners with founders at the earliest stages of company creation, pairing active partners (many former founders) with functional teams for go-to-market, recruiting, and other support.
▶33 more co-investors
Kleiner PerkinsSound VenturesStreamlined VenturesSusa VenturesInnovation EndeavorsSignalFireCrosslink CapitalMaveronM13Breakthrough Energy VenturesMMC VenturesBasementSRB VenturessequelDeerfield Management CompanySanofi VenturesAsset Management VenturesMechanism CapitalForesite CapitalCourtside VenturesTencent Holdings6 Dimensions CapitalaMoonGenoa VenturesDarco Capital4BIO CapitalSRI CapitalSharp AlphaGolden SeedsBreakout Ventures82VSGENERAL INCEPTIONOMX Ventures
Firms observed investing alongside Northpond Ventures, from public investor directories. Shared companies are the overlap with Northpond Ventures's recorded portfolio.
Similar investors
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Seventure Partners is a European venture capital firm investing across life sciences, digital technologies, sport and performance, and the blue economy.
Asia2G (A2G) Capital is a Silicon Valley venture capital firm that invests primarily in early-stage Korean and Asian technology startups seeking to expand globally.
Safar Partners is an early-stage technology investment firm that backs startups spun out of leading research universities, primarily MIT, Harvard, and the University of Rochester.